Moneycontrol Be a Pro
Get App
Last Updated : Apr 17, 2019 03:15 PM IST | Source: Moneycontrol.com

Dr Reddy’s Laboratories Q4 PAT seen up 36.9% YoY to Rs. 413.6 cr: Kotak

Net Sales are expected to increase by 7.7 percent Y-o-Y (down 1.1 percent Q-o-Q) to Rs. 3,807.5 crore, according to Kotak.

Moneycontrol News @moneycontrolcom
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Kotak has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Dr Reddy’s Laboratories to report net profit at Rs. 413.6 crore up 36.9% year-on-year (down 14.8% quarter-on-quarter).


Net Sales are expected to increase by 7.7 percent Y-o-Y (down 1.1 percent Q-o-Q) to Rs. 3,807.5 crore, according to Kotak.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 42.6 percent Y-o-Y (down 3.7 percent Q-o-Q) to Rs. 785.5 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.




The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .
First Published on Apr 17, 2019 03:15 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant